Categoria
Novo-Furantoin
Marchi,
Novo-Furantoin
Analoghi
Novo-Furantoin
Marchi miscela
No information avaliable
Novo-Furantoin
Formula chimica
C8H6N4O5
Novo-Furantoin
RX link
http://www.rxlist.com/cgi/generic/nitro25m.htm
Novo-Furantoin
FDA foglio
Novo-Furantoin
DMS (foglio di materiale di sicurezza)
Novo-Furantoin
Sintesi di riferimento
Nessuna informazione disponibile
Novo-Furantoin
Peso molecolare
238.157 g/mol
Novo-Furantoin
Temperatura di fusione
263 oC
Novo-Furantoin
H2O Solubilita
79,5 mg / L
Novo-Furantoin
Stato
Solid
Novo-Furantoin
LogP
-0.04
Novo-Furantoin
Forme di dosaggio
Compressa
Novo-Furantoin
Indicazione
Per il trattamento delle infezioni del tratto urinario
Novo-Furantoin
Farmacologia
Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.
Novo-Furantoin
Assorbimento
Nessuna informazione disponibile
Novo-Furantoin
Tossicita
Nessuna informazione disponibile
Novo-Furantoin
Informazioni paziente
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
Novo-Furantoin
Atto interessato organismi
Gram negativi e alcuni batteri gram-positivi